Table 1.
Controls (N = 10) |
All FXTAS (N = 38) |
Parkinsonism (N = 11) |
Non-Parkinsonism (N = 27) |
|
---|---|---|---|---|
Age | 64.3 (7.3) | 66.6 (8.2) | 67.1 (7.9) | 66.4 (8.4) |
Female (%) | 1 (10.0%) | 8 (21.0%) | 4 (36.4%) | 4 (14.8%) |
FXTAS stage | – | 3.05 (0.87) | 3.09 (0.70) | 3.04 (0.94) |
CGG repeats | – | 92.6 (19.6) | 93.2 (15.1) | 92.2 (21.9) |
CGG range | – | 57–141 | 74–119 | 57–141 |
mRNA | – | 3.13 (1.20) | 3.19 (0.98) | 3.10 (1.26) |